Drugs Approved for Hodgkin Lymphoma
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for Hodgkin lymphoma. The list includes generic and brand names. This page also lists common drug combinations used in Hodgkin lymphoma. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in Hodgkin lymphoma that are not listed here.
Adcetris (Brentuximab Vedotin)
Adriamycin PFS (Doxorubicin Hydrochloride)
Adriamycin RDF (Doxorubicin Hydrochloride)
Ambochlorin (Chlorambucil)
Amboclorin (Chlorambucil)
Blenoxane (Bleomycin)
Bleomycin
Brentuximab Vedotin
Chlorambucil
Clafen (Cyclophosphamide)
Cyclophosphamide
Cytoxan (Cyclophosphamide)
Dacarbazine
Doxorubicin Hydrochloride
DTIC-Dome (Dacarbazine)
Leukeran (Chlorambucil)
Linfolizin (Chlorambucil)
Lomustine
Matulane (Procarbazine Hydrochloride)
Neosar (Cyclophosphamide)
Procarbazine Hydrochloride
Velban (Vinblastine Sulfate)
Velsar (Vinblastine Sulfate)
Vinblastine Sulfate
Vincasar PFS (Vincristine Sulfate)
Vincristine Sulfate
Back to Top